Roche Molecular Systems, Inc.
Part of Foundation Medicine, Inc.
- UEI
- XML8DAL97854
- CAGE
- 1Q8H8
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Boston, MA
EHXPZ92G4AD1
-
Parent
Boston, MA
EHXPZ92G4AD1
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Chemonics International, Inc. | AIDOAATO1500007 | $127,727 | |
| Chemonics International, Inc. | AIDOAATO1500007 | $362,345,961 | |
| Chemonics International, Inc. | AIDOAATO1500007 | $214,025 |
Quick answers
Is Roche Molecular Systems, Inc. registered in SAM.gov?
Roche Molecular Systems, Inc.'s SAM.gov registration expired on May 6, 2017.
What is Roche Molecular Systems, Inc.'s most recent federal award?
Roche Molecular Systems, Inc.'s most recent federal contract award is Cobas zika testing for puerto rico blood supply (HHSO100201600010C), from Office of the Assistant Secretary for Preparedness and Response, on April 21, 2016.
On GovTribe
See Roche Molecular Systems, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors